Skip to main content

Table 1 Patient and Treatment Characteristics

From: Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided High Dose Rate brachytherapy boost

 

Patients Without PSA Bounce (n = 4)

Patients With PSA Bounce (n = 5)

P Value

Median Age (years)

67

62

NS

Largest Field Treated

   

Whole Pelvis Treated

0%

20%

NS

Prostate and Seminal Vesicles

75%

40%

NS

Prostate Only

25%

40%

NS

Concurrent Hormone Therapy

25%

60%

NS

T2b and greater tumor stage

0%

20%

NS

PSA less than 10

75%

80%

NS